Clinical Trial Data

No new efficacy or safety figures were disclosed in today’s announcement, but ANI Pharmaceuticals will showcase the already reported...

PharmAla Biotech has delivered over 500 capsules of its LaNeo 40mg MDMA to the Merhavim Mental Health Centre in...

Alterity Therapeutics announced positive topline data from its open-label Phase 2 clinical trial (ATH434-202) of ATH434 in individuals with...

A recent multi-center clinical trial published in the European Journal of Pediatrics demonstrated the safety and efficacy of Vivos...

In this interview, Rachael Thomas Higgins, Chief Commercial Officer of PicnicHealth, offers her perspective on the pivotal role of...

Exegenesis Bio, a leading genetic medicines company, unveiled encouraging clinical efficacy and safety results for their EXG001-307 gene therapy...

At the 2024 SCOPE Summit, Demetris Zambas, VP and Global Head of Data Monitoring and Management at Pfizer explored...

In this conversation with Jeffrey Sorenson, CEO at Yunu, we explore the transformative potential of treating imaging data as...

The industry loves to celebrate synthetic data as a privacy solution—but where’s the real impact? Let’s be clear: privacy...

Cross-border data transfers are a critical yet complex aspect in clinical trials. With global collaborations becoming the norm, personal...